Combinatory treatment of human and murine breast cancer cells with P005091 and the PI3K-inhibitors BEZ and BKM showed synergistic effects in colony formation assays (Supplementary Figures S19-S20). This evidence concerns the gene PIK3CA and breast carcinoma.